This page shows the details of why an item matched the keywords from your search.
Item Type | Name |
Concept
|
Cisplatin
|
Academic Article
|
New chemotherapy regimens for advanced bladder cancer.
|
Academic Article
|
[New chemotherapy regimens for advanced bladder cancer].
|
Academic Article
|
Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.
|
Academic Article
|
In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer.
|
Academic Article
|
Treatment of metastatic urothelial cancer in the post-MVAC era.
|
Academic Article
|
Gemcitabine doublets in advanced urothelial cancer.
|
Academic Article
|
Perioperative chemotherapy in locally advanced bladder cancer.
|
Academic Article
|
Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer.
|
Academic Article
|
A Phase II study of oxaliplatin in urothelial cancer.
|
Academic Article
|
Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer.
|
Academic Article
|
A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer.
|
Academic Article
|
Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
|
Academic Article
|
Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
|
Academic Article
|
A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma.
|
Academic Article
|
Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.
|
Academic Article
|
Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.
|
Academic Article
|
Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
|
Academic Article
|
Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.
|
Academic Article
|
A multicenter, double-blind, placebo-controlled randomized phase II trial of gemcitabine/cisplatin (GC) plus bevacizumab (B) or placebo in patients (pts) with malignant mesothelioma (MM).
|
Academic Article
|
Phase II trial of adjuvant gemcitabine plus cisplatin (GC) with amifostine cytoprotection in patients (pts) with locally advanced bladder cancer (BC).
|
Academic Article
|
Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin C.
|
Academic Article
|
Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance).
|
Academic Article
|
Bladder-Preserving Trimodality Therapy With Capecitabine.
|